# Joao Incio

> Joao Incio is a seed investor at Biovance Capital backing Medical and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Biovance Capital](https://shizune.co/investors/profile/biovance-capital)
- Total investments: 2
- Last investment: Mar 2026
- Lead investor: 100%
- Last updated: Aug 2026

Joao Incio is a seed investor at Biovance Capital focused on Medical and Biotechnology.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Biotechnology | 2 | 100% |
| Product Research | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Portugal | 1 | 50% |
| The Netherlands | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Laigo Bio | Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders. | $6.4M | Seed | Mar 23, 2026 |  |
| Mondego Bio | Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile. |  | Series A | Sep 18, 2025 |  |

2 of 2 investments shown.

## Co-investors
- [Angelini Ventures](https://shizune.co/investors/profile/angelini-ventures) — VC Fund, 1 deal together
- [ARGOBIO](https://shizune.co/investors/profile/argobio) — VC Fund, 1 deal together
- [Cancer Research Horizons](https://shizune.co/investors/profile/cancer-research-technology) — VC Fund, 1 deal together
- [Curie Capital](https://shizune.co/investors/profile/curie-capital) — VC Fund, 1 deal together
- [Eurazeo](https://shizune.co/investors/profile/eurazeo-com) — VC Fund, 1 deal together
- [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners) — VC Fund, 1 deal together

## About Biovance Capital

VC Fund · Lisbon, Portugal

Biovance Capital is a new € 51M fund to invest in early-stage biotech companies across Europe developing innovative therapeutics in all disease areas and drug modalities (small and large molecules, vaccines, cell, and gene therapies).

2 contacts available at Biovance Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Joao Incio | General Partner | https://shizune.co/investors/profile/joao-incio |
| Ricardo Perdigão Henriques | Managing Partner | https://shizune.co/investors/profile/ricardo-perdig%C3%A3o-henriques |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Joao Incio invest in?

Joao Incio invests primarily in Medical, Biotechnology and Product Research startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Portugal. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Joao Incio last invest?

The most recent investment recorded for Joao Incio closed in Mar 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co